

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 6.98099251 |
| 2 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 6.98099251 |
| 3 | regulation of translation, ncRNA-mediated (GO:0045974) | 6.98099251 |
| 4 | synaptic transmission, cholinergic (GO:0007271) | 6.94087694 |
| 5 | regulation of posttranscriptional gene silencing (GO:0060147) | 6.70857073 |
| 6 | regulation of gene silencing by miRNA (GO:0060964) | 6.70857073 |
| 7 | regulation of gene silencing by RNA (GO:0060966) | 6.70857073 |
| 8 | endoderm formation (GO:0001706) | 6.05551226 |
| 9 | protein polyglutamylation (GO:0018095) | 5.92831076 |
| 10 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 5.70752794 |
| 11 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 5.70752794 |
| 12 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.64723259 |
| 13 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 5.59136274 |
| 14 | regulation of synapse structural plasticity (GO:0051823) | 5.22520824 |
| 15 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 5.16073037 |
| 16 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 5.16073037 |
| 17 | cerebral cortex neuron differentiation (GO:0021895) | 4.99174441 |
| 18 | N-glycan processing (GO:0006491) | 4.96527785 |
| 19 | behavioral response to nicotine (GO:0035095) | 4.94304650 |
| 20 | postsynaptic membrane organization (GO:0001941) | 4.87434380 |
| 21 | olfactory bulb development (GO:0021772) | 4.74771627 |
| 22 | head development (GO:0060322) | 4.73706325 |
| 23 | nucleobase catabolic process (GO:0046113) | 4.73660698 |
| 24 | nuclear envelope reassembly (GO:0031468) | 4.64350330 |
| 25 | mitotic nuclear envelope reassembly (GO:0007084) | 4.64350330 |
| 26 | protein K11-linked deubiquitination (GO:0035871) | 4.41750723 |
| 27 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.37105603 |
| 28 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.25523144 |
| 29 | intraciliary transport (GO:0042073) | 4.24558276 |
| 30 | positive regulation of mRNA catabolic process (GO:0061014) | 3.99895107 |
| 31 | positive regulation of neurological system process (GO:0031646) | 3.87006540 |
| 32 | myoblast fusion (GO:0007520) | 3.73590122 |
| 33 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.68607409 |
| 34 | aggressive behavior (GO:0002118) | 3.62257774 |
| 35 | tachykinin receptor signaling pathway (GO:0007217) | 3.59332554 |
| 36 | positive regulation of mRNA 3-end processing (GO:0031442) | 3.53331170 |
| 37 | regulation of mRNA catabolic process (GO:0061013) | 3.48360001 |
| 38 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 3.44947801 |
| 39 | regulation of mRNA 3-end processing (GO:0031440) | 3.42909196 |
| 40 | central nervous system neuron axonogenesis (GO:0021955) | 3.39060240 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.31460814 |
| 42 | positive regulation of muscle cell apoptotic process (GO:0010661) | 3.27980172 |
| 43 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.21620761 |
| 44 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.21600557 |
| 45 | epithelial cilium movement (GO:0003351) | 3.21479193 |
| 46 | adaptation of signaling pathway (GO:0023058) | 3.20415786 |
| 47 | brain morphogenesis (GO:0048854) | 3.19579397 |
| 48 | syncytium formation (GO:0006949) | 3.18420356 |
| 49 | meiotic chromosome segregation (GO:0045132) | 3.15325484 |
| 50 | histone H3-K4 trimethylation (GO:0080182) | 3.05400398 |
| 51 | axon extension (GO:0048675) | 3.02860217 |
| 52 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.02182358 |
| 53 | establishment of monopolar cell polarity (GO:0061162) | 3.02182358 |
| 54 | cilium morphogenesis (GO:0060271) | 3.01296425 |
| 55 | spinal cord development (GO:0021510) | 2.98557472 |
| 56 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.94680505 |
| 57 | cell proliferation in forebrain (GO:0021846) | 2.88504539 |
| 58 | somite development (GO:0061053) | 2.88204297 |
| 59 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.85620469 |
| 60 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.84775650 |
| 61 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.84077835 |
| 62 | mitochondrion distribution (GO:0048311) | 2.79751423 |
| 63 | peptidyl-histidine modification (GO:0018202) | 2.77734687 |
| 64 | Sertoli cell development (GO:0060009) | 2.75403309 |
| 65 | behavioral response to ethanol (GO:0048149) | 2.74886993 |
| 66 | regulation of smooth muscle cell apoptotic process (GO:0034391) | 2.74446167 |
| 67 | ganglion development (GO:0061548) | 2.74257089 |
| 68 | regulation of hippo signaling (GO:0035330) | 2.73289506 |
| 69 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.73243898 |
| 70 | glycosphingolipid biosynthetic process (GO:0006688) | 2.71294090 |
| 71 | coenzyme catabolic process (GO:0009109) | 2.70060794 |
| 72 | positive regulation of mRNA processing (GO:0050685) | 2.68627445 |
| 73 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.68051628 |
| 74 | neuron projection extension (GO:1990138) | 2.66956294 |
| 75 | serotonin metabolic process (GO:0042428) | 2.66293920 |
| 76 | synapse assembly (GO:0007416) | 2.66184112 |
| 77 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.64808995 |
| 78 | detection of calcium ion (GO:0005513) | 2.64075381 |
| 79 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.63354305 |
| 80 | thyroid hormone metabolic process (GO:0042403) | 2.62498996 |
| 81 | negative regulation of multicellular organism growth (GO:0040015) | 2.62363923 |
| 82 | substantia nigra development (GO:0021762) | 2.62095765 |
| 83 | positive regulation of amino acid transport (GO:0051957) | 2.61723843 |
| 84 | negative regulation of sodium ion transport (GO:0010766) | 2.61525584 |
| 85 | regulation of Rac protein signal transduction (GO:0035020) | 2.58535740 |
| 86 | response to pheromone (GO:0019236) | 2.58134708 |
| 87 | neurofilament cytoskeleton organization (GO:0060052) | 2.58012309 |
| 88 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.57328594 |
| 89 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.55371648 |
| 90 | positive regulation of vesicle fusion (GO:0031340) | 2.55186351 |
| 91 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.54310109 |
| 92 | regulation of somitogenesis (GO:0014807) | 2.52709721 |
| 93 | presynaptic membrane assembly (GO:0097105) | 2.52258680 |
| 94 | establishment of nucleus localization (GO:0040023) | 2.50021944 |
| 95 | stress granule assembly (GO:0034063) | 2.49409566 |
| 96 | inositol metabolic process (GO:0006020) | 2.49245684 |
| 97 | transmission of nerve impulse (GO:0019226) | 2.48229940 |
| 98 | gene silencing by RNA (GO:0031047) | 2.47873225 |
| 99 | phospholipid translocation (GO:0045332) | 2.47684596 |
| 100 | lipid translocation (GO:0034204) | 2.47684596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.19615762 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.91572517 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.67584100 |
| 4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.59716976 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.58524848 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.49784339 |
| 7 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.48186251 |
| 8 | RNF2_27304074_Chip-Seq_NSC_Mouse | 2.19171718 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10715683 |
| 10 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.09922455 |
| 11 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.99870554 |
| 12 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97829730 |
| 13 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.90220451 |
| 14 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.88060827 |
| 15 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.86167563 |
| 16 | P300_19829295_ChIP-Seq_ESCs_Human | 1.84277018 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.83040757 |
| 18 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.82758395 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.81218497 |
| 20 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.76181312 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71647936 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68677417 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.64779538 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60287831 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60203121 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.59640980 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59368401 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.56417040 |
| 29 | STAT3_23295773_ChIP-Seq_U87_Human | 1.56022664 |
| 30 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.50972433 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.50361395 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.47859709 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44836095 |
| 34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44285404 |
| 35 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.43532480 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.41825821 |
| 37 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.40757397 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40753541 |
| 39 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39652738 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.39480919 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39342285 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39057838 |
| 43 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.37834053 |
| 44 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36324644 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.36121469 |
| 46 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.35131072 |
| 47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34495003 |
| 48 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.34495003 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34255249 |
| 50 | TP53_16413492_ChIP-PET_HCT116_Human | 1.33941151 |
| 51 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.33825989 |
| 52 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.32322829 |
| 53 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.31829242 |
| 54 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.31002616 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29477551 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29394759 |
| 57 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27295663 |
| 58 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.27077599 |
| 59 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.26947230 |
| 60 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.26721013 |
| 61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.26649009 |
| 62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26184760 |
| 63 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24130254 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23082248 |
| 65 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21273980 |
| 66 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20144254 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18238710 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18238710 |
| 69 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.17913161 |
| 70 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.17889732 |
| 71 | TBL1_22424771_ChIP-Seq_293T_Human | 1.16879065 |
| 72 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15990547 |
| 73 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15780747 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14276533 |
| 75 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13976214 |
| 76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.13757187 |
| 77 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13539911 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13335799 |
| 79 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.12949752 |
| 80 | AR_19668381_ChIP-Seq_PC3_Human | 1.12856265 |
| 81 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.12093125 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11899811 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.10391936 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10096617 |
| 85 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09569311 |
| 86 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.09550273 |
| 87 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.08524181 |
| 88 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.08260143 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07604589 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07419550 |
| 91 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.05722069 |
| 92 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05713401 |
| 93 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05612066 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05506600 |
| 95 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05058882 |
| 96 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04326828 |
| 97 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02879062 |
| 98 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01981630 |
| 99 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01981100 |
| 100 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01482922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005423_abnormal_somatic_nervous | 4.08028427 |
| 2 | MP0006072_abnormal_retinal_apoptosis | 3.74486725 |
| 3 | MP0003880_abnormal_central_pattern | 3.45583573 |
| 4 | MP0006276_abnormal_autonomic_nervous | 3.43459657 |
| 5 | MP0005083_abnormal_biliary_tract | 3.10445074 |
| 6 | MP0003787_abnormal_imprinting | 3.09876910 |
| 7 | MP0000778_abnormal_nervous_system | 3.04463626 |
| 8 | MP0004147_increased_porphyrin_level | 2.99724540 |
| 9 | MP0003879_abnormal_hair_cell | 2.95742057 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.92199804 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 2.73914427 |
| 12 | MP0008057_abnormal_DNA_replication | 2.62272244 |
| 13 | MP0003121_genomic_imprinting | 2.52108118 |
| 14 | MP0003122_maternal_imprinting | 2.25100548 |
| 15 | MP0000427_abnormal_hair_cycle | 2.20760049 |
| 16 | MP0005670_abnormal_white_adipose | 2.17407882 |
| 17 | MP0004043_abnormal_pH_regulation | 2.07554150 |
| 18 | MP0005253_abnormal_eye_physiology | 2.07209500 |
| 19 | MP0005645_abnormal_hypothalamus_physiol | 1.97579179 |
| 20 | MP0005171_absent_coat_pigmentation | 1.89483401 |
| 21 | MP0000955_abnormal_spinal_cord | 1.88584440 |
| 22 | MP0009046_muscle_twitch | 1.84891181 |
| 23 | MP0001324_abnormal_eye_pigmentation | 1.77947622 |
| 24 | MP0002234_abnormal_pharynx_morphology | 1.71747649 |
| 25 | MP0003123_paternal_imprinting | 1.71703874 |
| 26 | MP0002184_abnormal_innervation | 1.61487275 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.58936075 |
| 28 | MP0004142_abnormal_muscle_tone | 1.56693338 |
| 29 | MP0002751_abnormal_autonomic_nervous | 1.52152507 |
| 30 | MP0004885_abnormal_endolymph | 1.51860746 |
| 31 | MP0002009_preneoplasia | 1.45172874 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.41244433 |
| 33 | MP0002095_abnormal_skin_pigmentation | 1.38803923 |
| 34 | MP0002752_abnormal_somatic_nervous | 1.34075317 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.30715542 |
| 36 | MP0005195_abnormal_posterior_eye | 1.30624935 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.28804506 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.28339915 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.27608567 |
| 40 | MP0002735_abnormal_chemical_nociception | 1.24035448 |
| 41 | MP0001486_abnormal_startle_reflex | 1.23260467 |
| 42 | MP0001440_abnormal_grooming_behavior | 1.23225470 |
| 43 | MP0001905_abnormal_dopamine_level | 1.19693140 |
| 44 | MP0000566_synostosis | 1.17921793 |
| 45 | MP0000049_abnormal_middle_ear | 1.16970231 |
| 46 | MP0004084_abnormal_cardiac_muscle | 1.15823559 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.13274406 |
| 48 | MP0004924_abnormal_behavior | 1.12985547 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.12985547 |
| 50 | MP0003252_abnormal_bile_duct | 1.11536725 |
| 51 | MP0001188_hyperpigmentation | 1.10644911 |
| 52 | MP0003943_abnormal_hepatobiliary_system | 1.10138288 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.07590951 |
| 54 | MP0003635_abnormal_synaptic_transmissio | 1.05269431 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 1.03028844 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.01497409 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.01347231 |
| 58 | MP0009745_abnormal_behavioral_response | 1.00440365 |
| 59 | MP0000613_abnormal_salivary_gland | 1.00058434 |
| 60 | MP0002272_abnormal_nervous_system | 0.97896997 |
| 61 | MP0002269_muscular_atrophy | 0.95301970 |
| 62 | MP0003959_abnormal_lean_body | 0.94888154 |
| 63 | MP0002063_abnormal_learning/memory/cond | 0.92459064 |
| 64 | MP0002295_abnormal_pulmonary_circulatio | 0.91565160 |
| 65 | MP0000631_abnormal_neuroendocrine_gland | 0.88618331 |
| 66 | MP0001963_abnormal_hearing_physiology | 0.88540831 |
| 67 | MP0003115_abnormal_respiratory_system | 0.88504768 |
| 68 | MP0005174_abnormal_tail_pigmentation | 0.87474810 |
| 69 | MP0005391_vision/eye_phenotype | 0.83661985 |
| 70 | MP0002734_abnormal_mechanical_nocicepti | 0.83275841 |
| 71 | MP0001485_abnormal_pinna_reflex | 0.82993192 |
| 72 | MP0004133_heterotaxia | 0.82153970 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 0.80977843 |
| 74 | MP0002229_neurodegeneration | 0.80635407 |
| 75 | MP0003937_abnormal_limbs/digits/tail_de | 0.79631116 |
| 76 | MP0002928_abnormal_bile_duct | 0.79596848 |
| 77 | MP0003633_abnormal_nervous_system | 0.78623124 |
| 78 | MP0004484_altered_response_of | 0.77790074 |
| 79 | MP0001299_abnormal_eye_distance/ | 0.76768615 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.76627555 |
| 81 | MP0005266_abnormal_metabolism | 0.76574921 |
| 82 | MP0001286_abnormal_eye_development | 0.75880829 |
| 83 | MP0002282_abnormal_trachea_morphology | 0.75439169 |
| 84 | MP0008770_decreased_survivor_rate | 0.73689877 |
| 85 | MP0004859_abnormal_synaptic_plasticity | 0.73557575 |
| 86 | MP0000647_abnormal_sebaceous_gland | 0.73477946 |
| 87 | MP0004270_analgesia | 0.71836238 |
| 88 | MP0002733_abnormal_thermal_nociception | 0.71316629 |
| 89 | MP0003861_abnormal_nervous_system | 0.70444803 |
| 90 | MP0008995_early_reproductive_senescence | 0.70224408 |
| 91 | MP0003385_abnormal_body_wall | 0.69598416 |
| 92 | MP0004215_abnormal_myocardial_fiber | 0.69448696 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.68149255 |
| 94 | MP0005360_urolithiasis | 0.67598831 |
| 95 | MP0002152_abnormal_brain_morphology | 0.66771434 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 0.66274509 |
| 97 | MP0008775_abnormal_heart_ventricle | 0.64724087 |
| 98 | MP0001944_abnormal_pancreas_morphology | 0.64098261 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.64088020 |
| 100 | MP0000372_irregular_coat_pigmentation | 0.63944791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papilledema (HP:0001085) | 7.24504078 |
| 2 | Abnormality of the corticospinal tract (HP:0002492) | 5.53645704 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.17658898 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.17658898 |
| 5 | Spinal muscular atrophy (HP:0007269) | 4.82129939 |
| 6 | High anterior hairline (HP:0009890) | 3.73082709 |
| 7 | Shawl scrotum (HP:0000049) | 3.62963220 |
| 8 | Genetic anticipation (HP:0003743) | 3.54096031 |
| 9 | Coronal craniosynostosis (HP:0004440) | 3.52326883 |
| 10 | Molar tooth sign on MRI (HP:0002419) | 3.41615833 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.41615833 |
| 12 | Breast hypoplasia (HP:0003187) | 3.28890708 |
| 13 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.12081272 |
| 14 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.85000668 |
| 15 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.76458910 |
| 16 | Increased number of teeth (HP:0011069) | 2.76088352 |
| 17 | Diastasis recti (HP:0001540) | 2.75883423 |
| 18 | True hermaphroditism (HP:0010459) | 2.75686873 |
| 19 | Small hand (HP:0200055) | 2.70903851 |
| 20 | Nephronophthisis (HP:0000090) | 2.68393881 |
| 21 | Decreased muscle mass (HP:0003199) | 2.65949961 |
| 22 | Type 2 muscle fiber atrophy (HP:0003554) | 2.63501442 |
| 23 | Pancreatic fibrosis (HP:0100732) | 2.63106172 |
| 24 | Pancreatic cysts (HP:0001737) | 2.62841899 |
| 25 | Drooling (HP:0002307) | 2.61830001 |
| 26 | Pendular nystagmus (HP:0012043) | 2.58415210 |
| 27 | Lissencephaly (HP:0001339) | 2.57789824 |
| 28 | Thickened helices (HP:0000391) | 2.57021942 |
| 29 | Severe visual impairment (HP:0001141) | 2.56003504 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 2.53003511 |
| 31 | Exotropia (HP:0000577) | 2.49457233 |
| 32 | Truncal obesity (HP:0001956) | 2.48937024 |
| 33 | Polyphagia (HP:0002591) | 2.44740239 |
| 34 | Colon cancer (HP:0003003) | 2.42969667 |
| 35 | Hypercholesterolemia (HP:0003124) | 2.36877934 |
| 36 | Excessive salivation (HP:0003781) | 2.35835999 |
| 37 | Abnormality of incisor morphology (HP:0011063) | 2.34488971 |
| 38 | Insidious onset (HP:0003587) | 2.32868008 |
| 39 | Termporal pattern (HP:0011008) | 2.32868008 |
| 40 | Gait imbalance (HP:0002141) | 2.32626801 |
| 41 | Progressive cerebellar ataxia (HP:0002073) | 2.31988714 |
| 42 | Paraplegia (HP:0010550) | 2.23023093 |
| 43 | Nephrogenic diabetes insipidus (HP:0009806) | 2.22833516 |
| 44 | Pachygyria (HP:0001302) | 2.19866738 |
| 45 | Fatigable weakness (HP:0003473) | 2.17049664 |
| 46 | Abnormality of the neuromuscular junction (HP:0003398) | 2.17049664 |
| 47 | Muscle fiber atrophy (HP:0100295) | 2.16545657 |
| 48 | Irregular vertebral endplates (HP:0003301) | 2.15950441 |
| 49 | Nonprogressive disorder (HP:0003680) | 2.15614545 |
| 50 | Medial flaring of the eyebrow (HP:0010747) | 2.13316555 |
| 51 | Slow-growing hair (HP:0002217) | 2.13194609 |
| 52 | Abnormality of hair growth rate (HP:0011363) | 2.13194609 |
| 53 | Hypoplastic iliac wings (HP:0002866) | 2.12180337 |
| 54 | Down-sloping shoulders (HP:0200021) | 2.09179251 |
| 55 | Turricephaly (HP:0000262) | 2.08103017 |
| 56 | Midline defect of the nose (HP:0004122) | 2.07489025 |
| 57 | Abnormality of the renal medulla (HP:0100957) | 2.07230433 |
| 58 | Disproportionate short-trunk short stature (HP:0003521) | 2.04421953 |
| 59 | Weak cry (HP:0001612) | 2.03680097 |
| 60 | Poor coordination (HP:0002370) | 2.02829477 |
| 61 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.98821519 |
| 62 | Congenital primary aphakia (HP:0007707) | 1.96635185 |
| 63 | Birth length less than 3rd percentile (HP:0003561) | 1.96362007 |
| 64 | Trigonocephaly (HP:0000243) | 1.93024435 |
| 65 | Partial agenesis of the corpus callosum (HP:0001338) | 1.91001564 |
| 66 | Spastic tetraplegia (HP:0002510) | 1.90660885 |
| 67 | Chronic hepatic failure (HP:0100626) | 1.90360590 |
| 68 | Intestinal atresia (HP:0011100) | 1.89156629 |
| 69 | Woolly hair (HP:0002224) | 1.88392779 |
| 70 | Thickened nuchal skin fold (HP:0000474) | 1.86840864 |
| 71 | Focal seizures (HP:0007359) | 1.86776520 |
| 72 | Plagiocephaly (HP:0001357) | 1.84305176 |
| 73 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84030843 |
| 74 | Abnormal pancreas size (HP:0012094) | 1.82944671 |
| 75 | Labial hypoplasia (HP:0000066) | 1.81456146 |
| 76 | Occipital encephalocele (HP:0002085) | 1.80078049 |
| 77 | Fetal akinesia sequence (HP:0001989) | 1.79181957 |
| 78 | Sclerocornea (HP:0000647) | 1.78048018 |
| 79 | Cutaneous syndactyly (HP:0012725) | 1.75779011 |
| 80 | Sandal gap (HP:0001852) | 1.74613544 |
| 81 | Pterygium (HP:0001059) | 1.74284007 |
| 82 | Abnormality of the vertebral endplates (HP:0005106) | 1.74041691 |
| 83 | Absent speech (HP:0001344) | 1.72452882 |
| 84 | Agitation (HP:0000713) | 1.72405466 |
| 85 | Autoamputation (HP:0001218) | 1.71400933 |
| 86 | Attenuation of retinal blood vessels (HP:0007843) | 1.71173697 |
| 87 | Difficulty running (HP:0009046) | 1.71010706 |
| 88 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 1.70943292 |
| 89 | Urinary urgency (HP:0000012) | 1.69618155 |
| 90 | Preaxial foot polydactyly (HP:0001841) | 1.68792964 |
| 91 | Hip dysplasia (HP:0001385) | 1.68137668 |
| 92 | Abnormality of the ischium (HP:0003174) | 1.67444303 |
| 93 | Prolonged QT interval (HP:0001657) | 1.65742600 |
| 94 | Fibular hypoplasia (HP:0003038) | 1.65647712 |
| 95 | Papillary thyroid carcinoma (HP:0002895) | 1.63389336 |
| 96 | Abnormality of dental color (HP:0011073) | 1.63317819 |
| 97 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.62805813 |
| 98 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.62759004 |
| 99 | Oligodactyly (hands) (HP:0001180) | 1.61775839 |
| 100 | Cutaneous finger syndactyly (HP:0010554) | 1.61391784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB2 | 5.23012601 |
| 2 | DYRK1B | 4.59801877 |
| 3 | FRK | 3.86989536 |
| 4 | MARK1 | 3.42113845 |
| 5 | MAP3K12 | 2.99493245 |
| 6 | WNK3 | 2.56620021 |
| 7 | AKT3 | 2.39636901 |
| 8 | ICK | 2.15211600 |
| 9 | OXSR1 | 2.10555235 |
| 10 | NTRK1 | 1.96500528 |
| 11 | YES1 | 1.75631291 |
| 12 | DYRK2 | 1.74183430 |
| 13 | CASK | 1.72586655 |
| 14 | MAP3K6 | 1.62971704 |
| 15 | MAP3K11 | 1.55024523 |
| 16 | NTRK2 | 1.54760727 |
| 17 | NME1 | 1.53054580 |
| 18 | CDK19 | 1.45741876 |
| 19 | MKNK2 | 1.45388023 |
| 20 | GRK5 | 1.42557646 |
| 21 | PAK3 | 1.42070800 |
| 22 | CAMK1D | 1.37853462 |
| 23 | MAP3K4 | 1.37314349 |
| 24 | CSNK1G2 | 1.36769455 |
| 25 | SGK2 | 1.36329209 |
| 26 | CSNK1A1L | 1.35266748 |
| 27 | MARK2 | 1.33266552 |
| 28 | MAP2K7 | 1.32771949 |
| 29 | CAMK1G | 1.27003900 |
| 30 | CSNK1G3 | 1.20859416 |
| 31 | PIK3CA | 1.19203570 |
| 32 | MAP2K4 | 1.18425916 |
| 33 | MAPK13 | 1.16917423 |
| 34 | WNK4 | 1.16332926 |
| 35 | SIK2 | 1.15794216 |
| 36 | STK39 | 1.11589903 |
| 37 | BMPR1B | 1.10752632 |
| 38 | DYRK1A | 1.07828581 |
| 39 | PINK1 | 1.07229394 |
| 40 | SGK494 | 1.05010909 |
| 41 | SGK223 | 1.05010909 |
| 42 | GSK3A | 1.04432231 |
| 43 | PRKCZ | 1.03009657 |
| 44 | CAMKK2 | 1.02041920 |
| 45 | CDC7 | 1.01318214 |
| 46 | PRKCG | 1.00927014 |
| 47 | ERBB3 | 1.00362530 |
| 48 | CSNK1G1 | 1.00278210 |
| 49 | CHEK2 | 0.99085963 |
| 50 | FER | 0.91681710 |
| 51 | CAMK4 | 0.91503867 |
| 52 | CAMK1 | 0.87821436 |
| 53 | PLK2 | 0.87666572 |
| 54 | MINK1 | 0.84136714 |
| 55 | STK4 | 0.82154451 |
| 56 | STK11 | 0.79727078 |
| 57 | DAPK2 | 0.76116001 |
| 58 | CDK5 | 0.75291677 |
| 59 | GRK1 | 0.73947992 |
| 60 | NEK9 | 0.72351510 |
| 61 | STK3 | 0.72280078 |
| 62 | PAK6 | 0.69255620 |
| 63 | MARK3 | 0.67460263 |
| 64 | NUAK1 | 0.67339781 |
| 65 | PNCK | 0.65677120 |
| 66 | SGK3 | 0.65662515 |
| 67 | SGK1 | 0.64237656 |
| 68 | CDK14 | 0.63592640 |
| 69 | TNIK | 0.62574643 |
| 70 | EIF2AK2 | 0.60863933 |
| 71 | PRKAA1 | 0.59587688 |
| 72 | CHUK | 0.55641741 |
| 73 | TNK2 | 0.55545191 |
| 74 | UHMK1 | 0.53561929 |
| 75 | ROCK1 | 0.51768019 |
| 76 | STK38 | 0.50361759 |
| 77 | ADRBK2 | 0.50344356 |
| 78 | CSNK1D | 0.50309272 |
| 79 | PRKG1 | 0.48196344 |
| 80 | OBSCN | 0.43819452 |
| 81 | PRKCE | 0.43584512 |
| 82 | PLK4 | 0.43338422 |
| 83 | PKN1 | 0.43009455 |
| 84 | EPHB1 | 0.42995600 |
| 85 | PHKG1 | 0.42840794 |
| 86 | PHKG2 | 0.42840794 |
| 87 | CDK15 | 0.41689265 |
| 88 | CDK9 | 0.41344006 |
| 89 | CDK18 | 0.40828633 |
| 90 | CSNK1E | 0.40028109 |
| 91 | RPS6KA1 | 0.39746402 |
| 92 | WEE1 | 0.38230580 |
| 93 | MKNK1 | 0.35216447 |
| 94 | CDK11A | 0.35147370 |
| 95 | CSNK1A1 | 0.34871349 |
| 96 | BCR | 0.34325932 |
| 97 | MAPK8 | 0.32809064 |
| 98 | INSRR | 0.32713832 |
| 99 | CHEK1 | 0.32629797 |
| 100 | MAP3K7 | 0.31984447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 4.39409059 |
| 2 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 4.04810483 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.74006328 |
| 4 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.60164365 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.50479553 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.39409141 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.10865341 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.09554966 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.01502492 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.87948203 |
| 11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.80410267 |
| 12 | ABC transporters_Homo sapiens_hsa02010 | 1.72568168 |
| 13 | Axon guidance_Homo sapiens_hsa04360 | 1.68123603 |
| 14 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.60311552 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.51318867 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.48610305 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48369908 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.46794363 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.46245084 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.45432215 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.43386759 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.39444437 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.37059323 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.36636384 |
| 25 | Tight junction_Homo sapiens_hsa04530 | 1.36426920 |
| 26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.35243324 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26268641 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16327258 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.15913744 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.14163766 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.13946364 |
| 32 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.12576182 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.08966504 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08802574 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07368082 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.07309433 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00040654 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.97525283 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96345831 |
| 40 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.93408508 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93116232 |
| 42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.92112374 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 0.90930183 |
| 44 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90033107 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.88699945 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87789479 |
| 47 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.86956934 |
| 48 | Melanoma_Homo sapiens_hsa05218 | 0.84081259 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 0.80493507 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79040308 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77921547 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76843017 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76052687 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73572379 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 0.70213716 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69781046 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69434732 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68046975 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65593781 |
| 60 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65525540 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62982004 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62633041 |
| 63 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62217751 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62118224 |
| 65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60826486 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.59822650 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59028712 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.58584564 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.58305553 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.57299828 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56996270 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55904715 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55587324 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.55416818 |
| 75 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53360329 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52919230 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52828076 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52726622 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.52003627 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50625799 |
| 81 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50332078 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49354425 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49313398 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47607592 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.47447269 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46011963 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45085416 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43946679 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43847663 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43693905 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43466783 |
| 92 | RNA transport_Homo sapiens_hsa03013 | 0.42981123 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42829215 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41673025 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39179245 |
| 96 | Alcoholism_Homo sapiens_hsa05034 | 0.39071623 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37242174 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35211973 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33825742 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33653470 |

